Showing results (791-800 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1984
Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemiaM Hayat, P Hurteloup, C Parmentier, et al.Investigational New Drugs|January 1, 1984
Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinomaJ A WilsInvestigational New Drugs|October 26, 2019
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinomaJian Zhao, Junmei Lei, Junyan Yu, et al.Investigational New Drugs|October 23, 2019
Phase II study of apatinib, a novel tyrosine kinase inhibitor targeting tumor angiogenesis, as second-line treatment for recurrent or advanced cervical cancer patientsLinlin Zhang, Liang Chen, Hao YuInvestigational New Drugs|March 10, 2023
A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studiesDanny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.Investigational New Drugs|April 24, 2015
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapyHeloisa Veasey Rodrigues, Danxia Ke, JoAnn Lim, et al.Investigational New Drugs|January 1, 1984
A Phase I trial of spirogermanium administered on a continuous infusion scheduleP V Woolley, J D Ahlgren, P J Byrne, et al.Investigational New Drugs|January 1, 1984
Phase II trial of mitoxantrone in head and neck cancerM S Aapro, D S AlbertsInvestigational New Drugs|January 1, 1984
Advantages of integrated trials for performing multiple Phase II studiesG B Weiss, J A HokansonInvestigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.Pageof 372